"Methylphenidate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
| Descriptor ID |
D008774
|
| MeSH Number(s) |
D02.241.223.601.600 D03.383.621.460
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Methylphenidate".
Below are MeSH descriptors whose meaning is more specific than "Methylphenidate".
This graph shows the total number of publications written about "Methylphenidate" by people in this website by year, and whether "Methylphenidate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 6 | 0 | 6 |
| 2001 | 3 | 0 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 0 | 1 |
| 2006 | 5 | 2 | 7 |
| 2007 | 1 | 1 | 2 |
| 2008 | 7 | 0 | 7 |
| 2009 | 5 | 2 | 7 |
| 2010 | 5 | 0 | 5 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methylphenidate" by people in Profiles.
-
Sleep disturbance in patients with cancer: a feasibility study of multimodal therapy. BMJ Support Palliat Care. 2021 Jun; 11(2):170-179.
-
Variability of kinematic graphomotor fluency in adults with ADHD. Hum Mov Sci. 2014 Dec; 38:331-42.
-
Dopamine and norepinephrine receptors participate in methylphenidate enhancement of in vivo hippocampal synaptic plasticity. Neuropharmacology. 2015 Mar; 90:23-32.
-
Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol. 2013 Jul 01; 31(19):2421-7.
-
Iron status in toddlerhood predicts sensitivity to psychostimulants in children. J Atten Disord. 2012 May; 16(4):295-303.
-
Challenge of managing cancer-related fatigue. J Clin Oncol. 2010 Aug 10; 28(23):3671-2.
-
Treatment of cancer-related fatigue: an update. Support Care Cancer. 2003 Feb; 11(2):79-83.
-
Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: a pilot study. J Neuropsychiatry Clin Neurosci. 1997; 9(1):29-36.
-
Paroxysmal kinesigenic dystonia after methylphenidate administration. J Child Neurol. 1994 Jan; 9(1):45-6.
-
Noradrenergic and cholinergic agents in Korsakoff's syndrome. Clin Neuropharmacol. 1986; 9(1):65-70.